Finanzwire Finanzwire
Basculer en Français
10314 Companies
213758 Keywords
143411 Articles
113124 Press releases
Headlines Articles Press releases Generate:Biomedicines Remove
  1. Home
  2. Companies
  3. Generate:Biomedicines
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/01/2025 at 12:10, 4 months 28 days ago

    Generate:Biomedicines Initiates Phase 3 Trials for Asthma Antibody GB-0895

    Phase 3 Trials Generate:Biomedicines GB-0895 Asthma Treatment AI Engineered Antibody
  • PRESS RELEASE

    published on 12/01/2025 at 12:05, 4 months 28 days ago

    Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

    Generate:Biomedicines to initiate global Phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI. SOLAIRIA-1 and SOLAIRIA-2 will evaluate efficacy in reducing asthma exacerbations, reflecting commitment to developing innovative therapies
    AI Engineering Phase 3 Studies Generate:Biomedicines GB-0895 Severe Asthma
    Logo of Generate:Biomedicines
Accesswire
  • Published on 04/29/2026 at 12:00, 47 minutes ago

    Critical Elements Provides Assay Results on Its 10,000-Metre Drill Program at Rose West

  • Published on 04/29/2026 at 08:00, 4 hours 47 minutes ago

    Galantas Report Financial Results For The Year Ended December 31, 2025

  • Published on 04/29/2026 at 08:00, 4 hours 47 minutes ago

    Grande Portage Resources Initiates Full Scale Geochemical Characterization Program and Backfill Testwork for the New Amalga Gold Project

  • Published on 04/29/2026 at 05:10, 7 hours 37 minutes ago

    Silver Spruce Resources Inc. Announces Adjournment of Annual General and Special Meeting of Shareholders

  • Published on 04/29/2026 at 04:50, 7 hours 57 minutes ago

    Alaska Energy Metals Extends Marketing Services Engagement

View all ACCESSWIRE
EQS Group
  • Published on 04/29/2026 at 12:05, 42 minutes ago

    Cognizant to Acquire Astreya, Deepening Its AI-First Managed Services Capabilities at Scale

  • Published on 04/29/2026 at 12:05, 42 minutes ago

    Voltatron AG Enters Next Phase of Growth – Christian Eibach Appointed Chief Sales Officer with a Focus on Organic, International Growth

  • Published on 04/29/2026 at 12:00, 47 minutes ago

    The NAGA Group: SMC Research confirms “Speculative Buy” rating and price target of EUR 9.50

  • Published on 04/29/2026 at 11:37, 1 hour 10 minutes ago

    BALFIN Group signals Germany expansion through Austria investments

  • Published on 04/29/2026 at 11:28, 1 hour 19 minutes ago

    Logwin’s first quarter of 2026 characterized by challenging conditions

View all EQS
Les Echos
  • Published on 04/29/2026 at 10:15, 2 hours 32 minutes ago

    Neoen launches construction of two new solar farms in Ireland, nearly doubling its capacity in the country

  • Published on 04/29/2026 at 09:00, 3 hours 47 minutes ago

    Aéroports de Paris SA - Terms of availability or consultation of the information mentioned in Article R.225-83 of the French Commercial Code, relating to the combined general meeting (ordinary and extraordinary) of 21 May 2026

  • Published on 04/29/2026 at 07:30, 5 hours 17 minutes ago

    Signing of the SPA for the sale of Novacel

  • Published on 04/28/2026 at 18:00, 18 hours 47 minutes ago

    LDC has received approval from the Competition and Markets Authority (CMA) for the acquisition of shares in Green Label

  • Published on 04/28/2026 at 17:57, 18 hours 50 minutes ago

    Peugeot Invest enters into an agreement to sell its stake in Immobilière Dassault for €75 million

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy